Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Antivenom under the microscope: Real-World test in cameroon

NCT ID NCT03326492

Disease control Sponsor: Institut Pasteur Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at how well and how safely the antivenom Inoserp Pan-Africa® works for snake bites in everyday hospital settings in Cameroon. Researchers followed 474 patients over 5 years old who came to participating centers after a snake bite. The goal was to check for allergic reactions within 2 hours and see if the antivenom stopped the venom's effects over the next 48 hours.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Inoserp Pan-Africa® antivenom
What this could lead to
If successful, this could confirm that the antivenom is safe and works well in real-world settings, helping improve snakebite treatment in Africa.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. Allergic reactions to antivenom are a known risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

474 people

The number who actually took part.

Started

Oct 2019

Finished

Sep 2021

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Any patient over 5 years old (inclusive) visiting at a participating center for curative care following a snake bite, with or without confirmed envenoming, will be proposed to participate in the study

Ages

5 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Any patient over 5 years old (inclusive) visiting at a participating center for a snake bite with or without confirmed envenoming * Informed consent to research Exclusion Criteria: * Patient refusal * Under 5 year-old * Antivenom serum administration before the arrival in the participating center * History of severe allergic reactions to antivenom serum

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Antivenins are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Snake Bites snakebite envenomation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Antivenins Snake bites Snake venoms

Contacts and locations

Locations

  • Centre des Urgences de Yaounde (CURY)

    Yaoundé, Cameroon

  • Hôpital Norvégien de N'Gaoundéré

    N'Gaoundéré, Cameroon

  • Hôpital Régional de Limbe

    Limbe, Cameroon

  • Hôpital Régional de N'Gaoundéré

    N'Gaoundéré, Cameroon

  • Hôpital Saint Malte de Njombe

    Njombé, Cameroon

  • Hôpital de District d'Akonolinga

    Akonolinga, Cameroon

  • Hôpital de District de Guider

    Guider, Cameroon

  • Hôpital de District de Kolofata

    Kolofata, Cameroon

  • Hôpital de District de Mora

    Mora, Cameroon

  • Hôpital de District de Poli

    Poli, Cameroon

  • Hôpital de District de Sa'a

    Sa'a, Cameroon

  • Hôpital de District de Tokombere

    Tokonbéré, Cameroon

  • Hôpital régional de Buea

    Buea, Cameroon

More trials for these conditions

Other studies related to the condition(s) this trial covers.